EGFR and pancreatic neoplasm: For example, in pancreatic cancer, ALKBH1 functions as a demethylase of m1A modification, participating in the occurrence and development of pancreatic cancer through the mTOR and ErbB signalling pathways, and its low expression is related to the poor prognosis of patients [27].